Kite Pharma appoints Chris Nowers as its head of Europe
A seasoned executive with 30 years of commercial leadership experience in pharmaceutical, biotech and diagnostics companies, Mr. Nowers brings a track record of successfully driving differentiated strategies for product commercialization across therapeutic areas in a competitive global landscape.
Prior to joining Kite, Mr. Nowers held senior commercial leadership positions at Bristol-Myers Squibb, including Head of Immuno-oncology and Hematology in France, where he led the successful launch of Opdivo (nivolumab), and as Vice President of Global Commercialization for Yervoy (ipilimumab), where he led the global commercial launch.
Previously, Mr. Nowers was Vice President of Sales and Marketing at Genomic Health, Inc., and Chief Executive Officer of Avantogen Oncology Inc., a company developing early-stage cancer therapeutics.
He also served 11 years at Amgen Inc. in a variety of commercial leadership roles, including Global Commercial Leader for Neurology and European Director for Oncology and Hematology. ■
What to read next
LATEST MOVES FROM California
- NuVasive appoints Rajesh J. Asarpota as CFO
- Sanmina appoints David Anderson as CFO
- RPX Corporation appoints Marty Roberts to board
- Pfenex appoints Evert Schimmelpennink as CEO
- Aqua Metals appoints Mark Weinswig as CFO
More inside POST